Skip to content

Protea Biosciences Group, Inc.: 10-Q filed 2016-08-15

What Protea Biosciences Group, Inc. reported in its quarterly report filed 2016-08-15 (fiscal Q2 2016): 33 published measures, 94 facts as tagged in accession 0001144204-16-119366.

This filing

Form
10-Q (quarterly report)
Filed
2016-08-15
Fiscal period
fiscal Q2 2016
Accession
0001144204-16-119366 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Protea Biosciences Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-06-303,669,846USD
At 2015-12-313,043,746USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-06-3014,528,465USD
At 2015-12-3111,316,328USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-06-30-10,858,619USD
At 2015-12-31-8,272,582USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-06-30174,005USD
At 2015-12-316,450USD
At 2015-06-30121,366USD
At 2014-12-31322,877USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-1,807,598USD91
2016-01-01 to 2016-06-30-2,893,141USD182
2015-04-01 to 2015-06-30-2,304,908USD91
2015-01-01 to 2015-06-30-5,272,406USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-06-30-82,490,749USD
At 2015-12-31-79,597,608USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2016-04-01 to 2016-06-300USD91
2016-01-01 to 2016-06-300USD182
2015-04-01 to 2015-06-300USD91
2015-01-01 to 2015-06-300USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-06-302,846,519USD
At 2015-12-312,626,907USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2016-01-01 to 2016-06-30122,223USD182
2015-01-01 to 2015-06-30159,154USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-1,435,482USD91
2016-01-01 to 2016-06-30-3,001,532USD182
2015-04-01 to 2015-06-30-1,802,570USD91
2015-01-01 to 2015-06-30-3,947,098USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-06-30818,079USD
At 2015-12-31411,591USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2016-04-01 to 2016-06-30373,345USD91
2016-01-01 to 2016-06-30523,674USD182
2015-04-01 to 2015-06-30326,891USD91
2015-01-01 to 2015-06-30490,941USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-06-309,609,957USD
At 2015-12-319,590,170USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2016-06-30375,081USD
At 2015-12-31195,823USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2016-06-30146,946USD
At 2015-12-31111,087USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2016-04-01 to 2016-06-3092,159USD91
2016-01-01 to 2016-06-30363,122USD182
2015-04-01 to 2015-06-30286,873USD91
2015-01-01 to 2015-06-30532,836USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2016-04-01 to 2016-06-30489,605USD91
2016-01-01 to 2016-06-30693,980USD182
2015-04-01 to 2015-06-30171,203USD91
2015-01-01 to 2015-06-30315,769USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2016-04-01 to 2016-06-301,388,139USD91
2016-01-01 to 2016-06-302,992,542USD182
2015-04-01 to 2015-06-301,782,828USD91
2015-01-01 to 2015-06-303,790,569USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-04-01 to 2016-06-30139,502USD91
2016-01-01 to 2016-06-30372,112USD182
2015-04-01 to 2015-06-30306,615USD91
2015-01-01 to 2015-06-30689,365USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-06-30133,720,519shares
At 2015-12-31133,146,250shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-06-3071,618,843USD
At 2015-12-3171,311,572USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2016-06-30-85USD
At 2015-12-31139USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2016-06-305,240,425USD
At 2015-12-314,934,321USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2016-06-305,248USD
At 2015-12-315,248USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-06-3035,209USD
At 2015-12-3128,728USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-1,807,598USD91
2016-01-01 to 2016-06-30-2,893,141USD182
2015-04-01 to 2015-06-30-2,304,908USD91
2015-01-01 to 2015-06-30-5,272,406USD181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-1,807,870USD91
2016-01-01 to 2016-06-30-2,893,365USD182
2015-04-01 to 2015-06-30-2,304,251USD91
2015-01-01 to 2015-06-30-5,272,141USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2016-04-01 to 2016-06-30160,135USD91
2016-01-01 to 2016-06-30319,128USD182
2015-04-01 to 2015-06-30181,084USD91
2015-01-01 to 2015-06-30356,055USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-45USD91
2016-01-01 to 2016-06-301,341USD182
2015-04-01 to 2015-06-304,462USD91
2015-01-01 to 2015-06-306,003USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-372,116USD91
2016-01-01 to 2016-06-30108,391USD182
2015-04-01 to 2015-06-30-502,338USD91
2015-01-01 to 2015-06-30-1,325,308USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-06-30179,258USD182
2015-01-01 to 2015-06-3024,024USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-06-30-521USD182
2015-01-01 to 2015-06-30-149,379USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-06-30-39,164USD182
2015-01-01 to 2015-06-3035,787USD181

Inspect the source

Entity
Protea Biosciences Group, Inc. / CIK 0001335103
Captured
SEC response SHA-256
6b487b6d6aa0a735e07855358b10c0014003743452cad5b8c8bf2155ac6c1078

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001335103.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))